Sattari Shahab Aldin, Antar Albert, Sattari Ali Reza, Feghali James, Hung Alice, Lee Ryan P, Yang Wuyang, Kim Jennifer E, Johnson Emily, Young Christopher C, Xu Risheng, Caplan Justin M, Huang Judy, Tamargo Rafael J, Gonzalez L Fernando
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Surgery, Saint Agnes Hospital, Baltimore, Maryland, USA.
World Neurosurg. 2023 Sep;177:39-58. doi: 10.1016/j.wneu.2023.05.033. Epub 2023 May 16.
Randomized controlled trials comparing endovascular thrombectomy (EVT) versus EVT preceded by intravenous thrombolysis (EVT + IVT) for acute ischemic stroke due to large artery occlusion remain controversial. This systematic review and meta-analysis seek to compare these 2 modalities.
Online Protocol is available at PROSPERO (york.ac.uk) (registration# CRD42022357506). MEDLINE, PubMed, and Embase were searched. The primary outcome was 90-day modified Rankin scale (mRS) ≤2. Secondary outcomes were 90-day mRS ≤1, 90-day mean mRS, National Institutes of Health Stroke Scale (NIHSS) at 1-3 and 3-7 days, 90-day Barthel Index, 90-day EQ-5D-5L (EuroQoL Group 5-Dimension 5-Level), the volume of infarction (mL), successful reperfusion, complete reperfusion, recanalization, 90-day mortality, any intracranial hemorrhage (ICH), symptomatic ICH, embolization in new territory, new infarction, puncture site complications, vessel dissection, and contrast extravasation. The certainty in the evidence was determined by the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach.
Six randomized controlled trials yielding 2332 patients were included, of which 1163 and 1169 underwent EVT and EVT + IVT, respectively. The relative risk (RR) of 90-day mRS ≤2 was similar between the groups (RR = 0.96[0.88, 1.04]; P = 0.28). EVT was non-inferior to EVT + IVT because the lower bond of 95% confidence interval of the risk difference (RD = -0.02 [-0.06, 0.02]; P = 0.36) exceeded the -0.1 non-inferiority margin. The certainty in the evidence was high. The RR of successful reperfusion (RR = 0.96 [0.93, 0.99]; P = 0.006), any ICH (RR = 0.87 [0.77, 0.98]; P = 0.02), and puncture site complications (RR = 0.47 [0.25, 0.88]; P = 0.02) were lower with EVT. For EVT + IVT, the number needed to treat for successful reperfusion was 25, and the number needed to harm for any ICH was 20. The 2 groups were similar in other outcomes.
EVT is non-inferior to EVT + IVT. In centers capable of both EVT and IVT, if timely EVT is feasible, it is reasonable to skip bridging IVT and keep rescue thrombolysis at the discretion of the interventionist for patients presenting within 4.5 hours of anterior ischemic stroke.
对于大动脉闭塞所致急性缺血性卒中,比较血管内血栓切除术(EVT)与静脉溶栓后行血管内血栓切除术(EVT + IVT)的随机对照试验仍存在争议。本系统评价和荟萃分析旨在比较这两种治疗方式。
在线方案可在PROSPERO(york.ac.uk)获取(注册号CRD42022357506)。检索了MEDLINE、PubMed和Embase。主要结局为90天改良Rankin量表(mRS)评分≤2。次要结局包括90天mRS评分≤1、90天平均mRS评分、第1 - 3天和第3 - 7天的美国国立卫生研究院卒中量表(NIHSS)评分、90天Barthel指数、90天EQ - 5D - 5L(欧洲生活质量五维度五级量表)、梗死体积(mL)、成功再灌注、完全再灌注、血管再通、90天死亡率、任何颅内出血(ICH)、症状性ICH、新区域栓塞、新梗死、穿刺部位并发症、血管夹层和造影剂外渗。证据的确定性采用GRADE(推荐分级评估、制定和评价)方法确定。
纳入了6项随机对照试验,共2332例患者,其中1163例接受了EVT,1169例接受了EVT + IVT。两组90天mRS评分≤2的相对风险(RR)相似(RR = 0.96[0.88, 1.04];P = 0.28)。EVT不劣于EVT + IVT,因为风险差异(RD)的95%置信区间下限(RD = -0.02[-0.06, 0.02];P = 0.36)超过了 -0.1的非劣效界值。证据的确定性较高。EVT组成功再灌注(RR = 0.96[0.93, 0.99];P = 0.006)、任何ICH(RR = 0.87[0.77, 0.98];P = 0.02)和穿刺部位并发症(RR = 0.47[0.25, 0.88];P = 0.02)的RR较低。对于EVT + IVT,成功再灌注所需治疗人数为25,任何ICH的有害事件所需治疗人数为20。两组在其他结局方面相似。
EVT不劣于EVT + IVT。在具备EVT和IVT能力的中心,如果及时进行EVT可行,对于在前循环缺血性卒中发病4.5小时内就诊的患者,跳过桥接静脉溶栓并由介入医生酌情保留挽救性溶栓是合理的。